GO
Loading...
 

Acorda CEO Projects $255 Million From AMPYRA

Tue 19 Jun 12 | 06:45 PM ET
 Highlight transcript below to create clip
Transcript:  Print  |  Email
    This term does not appear
Go
 Click text to jump within video

Acorda CEO Projects $255 Million From AMPYRA

Tue 19 Jun 12 | 06:45 PM ET
Ron Cohen, Acorda Therapeutics president & CEO, offers insight on just how much potential his company's multiple sclerosis drug "AMPYRA" has in the pharmaceutical market.
 
RELATED ARTICLES AND CONTENT
More Videos
Latest Videos
Luxury rental boom ... in Jersey
Fri 18 Apr 14 | 12:00 PM ET
Latest Videos
Great growth expectations
Fri 18 Apr 14 | 11:00 AM ET
Latest Videos
Remodeling & insurance costs
Fri 18 Apr 14 | 09:00 AM ET
Latest Videos
Cramer wishes CNBC a Happy 25th birthday!
Thu 17 Apr 14 | 06:40 PM ET
Go
Displaying results for: Latest Video | US